| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.05 | 0.4 |